IC Trials
United States, Nashville Tennessee
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Tampa Florida
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Denver Colorado
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Detroit Michigan
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Palo Alto California
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Seattle Washington
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Cleveland Ohio
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Houston Texas
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Jacksonville Florida
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Boston Massachusetts
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Boston Massachusetts
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, New York New York
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Buffalo New York
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Rochester Minnesota
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Boston Massachusetts
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Chapel Hill North Carolina
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
Spain, Madrid Comunidad de Madrid
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
Spain, Madrid Comunidad de Madrid
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
Spain, Pamplona Navarra
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
France, Paris Île-de-France
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Chicago Illinois
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Miami Florida
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
Spain, Madrid Comunidad de Madrid
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
France, Villejuif Île-de-France
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Boston Massachusetts
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Tampa Florida
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Jacksonville Florida
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Denver Colorado
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Boston Massachusetts
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Cleveland Ohio
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, New York New York
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Buffalo New York
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Houston Texas
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Nashville Tennessee
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Boston Massachusetts
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
Germany, Hanover Lower Saxony
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Chicago Illinois
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
Germany, Leipzig Saxony
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
Germany, Dresden Sachsen
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States,
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
- Warm Autoimmune Hemolytic Anemia Clinical Trial
- Recruiting - NCT05786573
- PW TEST PGTCS
- Recruiting - PWTID0817202302
United States, Aurora Colorado
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Eugene Oregon
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Fairfax Virginia
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Austin Texas
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Tucson Arizona
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
South Korea, Seoul
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
South Korea, Seoul
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
South Korea, Seoul
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
South Korea, Seoul
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
South Korea, Incheon
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
South Korea, Seoul
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
South Korea, Goyang-si Gyeonggi-do
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
South Korea, Daegu
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
South Korea, Seoul
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
Spain, Salamanca Castilla y León
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
South Korea, Seoul
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
South Korea, Seoul
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Duarte California
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
Belgium, Gent Vlaams Gewest
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
Belgium, Edegem Vlaams Gewest
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
Belgium, Brugge Vlaams Gewest
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
Belgium, Leuven Vlaams Gewest
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
Taiwan, Taipei City
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
South Korea, Seoul
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
Taiwan,
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
Taiwan, Tainan City
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
Taiwan, Taichung City
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
United States, Hines Illinois
- Mild Traumatic Brain Injury & PTSD Study
- Recruiting - NCT03819608
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Hines Illinois
- Mild Traumatic Brain Injury & PTSD Study
- Recruiting - NCT03819608
United States, Columbus Ohio
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Naples Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Rock Hill South Carolina
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, San Antonio Texas
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Newport Beach California
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Miami Lakes Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, DuBois Pennsylvania
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Franklin Tennessee
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Winston-Salem North Carolina
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Palm Springs California
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Clearwater Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Kissimmee Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Towson Maryland
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Charleston South Carolina
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Brandon Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Palm Springs California
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Charlotte North Carolina
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Kissimmee Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Lafayette Colorado
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, San Diego California
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Ventura California
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Newport Beach California
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Gastonia North Carolina
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Williamsburg Virginia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Mesquite Texas
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, New York New York
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Omaha Nebraska
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Fort Lauderdale Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Miami Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Toms River New Jersey
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Palm Springs California
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Leesburg Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Rincon Georgia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Conway Arkansas
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Town and Country Missouri
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Anderson South Carolina
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Los Angeles California
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Washington District of Columbia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Columbia Maryland
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, St. Petersburg Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Portland Oregon
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, New Port Richey Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, McKinney Texas
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Cypress Texas
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Cincinnati Ohio
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Tyler Texas
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, St. Petersburg Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Kansas City Kansas
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Potsdam New York
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Farmington Connecticut
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Orlando Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Baltimore Maryland
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Vancouver Washington
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Sebring Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Philadelphia Pennsylvania
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, New Orleans Louisiana
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, St. Louis Missouri
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Denver Colorado
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Salt Lake City Utah
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Birmingham Alabama
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Huntersville North Carolina
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Worcester Massachusetts
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Sarasota Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Los Angeles California
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Springfield Massachusetts
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Little Rock Arkansas
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Mineola New York
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Laurens South Carolina
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Doylestown Pennsylvania
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, New York New York
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Fayetteville New York
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Canada, Saint-Charles-Borromée Québec
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Canada, Toronto Ontario
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, New Orleans Louisiana
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
Australia, Kent Town South Australia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Australia, Spearwood Western Australia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Australia, South Brisbane Queensland
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Australia, Greenslopes Queensland
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
Australia, Concord West New South Wales
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
Australia, Nedlands Western Australia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Australia, New Lambton Heights New South Wales
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
Australia, Trinity Park Queensland
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Australia, Westmead New South Wales
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
Australia, Clayton Victoria
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
Australia, Box Hill Victoria
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
Australia, Woodville South South Australia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Australia, Kogarah New South Wales
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Australia, Chermside Queensland
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
Australia, Murdoch Western Australia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Australia, Bedford Park South Australia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Australia, Adelaide South Australia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Santa Barbara California
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
New Zealand, Hamilton Waikato
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
New Zealand, Auckland Auckland
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
New Zealand, Christchurch Canterbury
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
New Zealand, Auckland Auckland
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
New Zealand, Tauranga Bay of Plenty
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
New Zealand, Wellington Wellington
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
New Zealand, Waikanae Wellington
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
New Zealand, Dunedin Otago
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
New Zealand, Auckland Auckland
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
Canada, Montréal Québec
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Maywood Illinois
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Iowa City Iowa
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Galveston Texas
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Chile, Providencia Región Metropolitana
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Chile, Providencia Región Metropolitana
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Dallas Texas
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Augusta Georgia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Jacksonville Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Port Richey Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Cleveland Ohio
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, Sacramento California
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Princeton New Jersey
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Los Angeles California
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Orlando Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Peru, Chancay Gobierno Regional de Lima
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Colombia, Medellín Antioquia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Colombia, Bucaramanga Santander
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Colombia, Zipaquirá Cundinamarca
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Peru, Piura Piura
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Sandy Springs Georgia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Lincoln Nebraska
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Chicago Illinois
- Mild Traumatic Brain Injury & PTSD Study
- Recruiting - NCT03819608
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Mexico, Monterrey Nuevo León
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Ireland, Limerick County Limerick
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Ireland, Dublin County Dublin
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Ireland, Baile Átha Cliath Contae Bhaile Átha Cliath
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Ireland, Dublin County Dublin
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Mexico, Guadalajara Jalisco
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Israel, Tel Aviv-Yafo Tel Aviv District
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Mexico, Monterrey Nuevo León
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Mexico, Guadalajara Jalisco
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Mexico, Durango Durango
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Mexico, Guadalajara Jalisco
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Mexico, Guadalajara Jalisco
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Colombia, Bogotá Cundinamarca
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, San Diego California
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Cleveland Ohio
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Plantation Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Malaysia, Batu Caves Selangor
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Malaysia, Kuala Lumpur Federal Territory of Kuala Lumpur
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Malaysia, Kota Bharu Kelantan
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Malaysia, Kuantan Pahang
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Malaysia, Kuala Lumpur Wilayah Persekutuan Kuala Lumpur
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Malaysia, Kuching Sarawak
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Fresno California
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, New York
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United Kingdom, Chertsey England
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United Kingdom, Wales
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United Kingdom, Northern Ireland
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United Kingdom, Cringleford England
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Netherlands, Arnhem Gelderland
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Netherlands, Heerlen Limburg
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Netherlands, Rotterdam South Holland
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Spain, Santiago de Compostela Galicia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Spain, Barcelona Catalunya
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United Kingdom, Cambridge England
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United Kingdom, Birmingham England
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United Kingdom, Exeter England
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United Kingdom, Southampton England
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Spain, L'Hospitalet de Llobregat Catalonia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Spain, Madrid Community of Madrid
- Myelodysplastic Syndromes Clinical Trial
- Recruiting - NCT02841540
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Belgium, Mechelen Vlaams Gewest
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
United States, Charlotte North Carolina
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Spain, Barcelona Catalonia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Brazil, Santa Catarina
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Brazil, São Paulo
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Brazil, Maranhão
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Brazil, Porto Alegre State of Rio Grande do Sul
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Brazil, São Paulo
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Brazil, Rio de Janeiro
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Brazil, Botucatu State of São Paulo
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Chile, Quillota Valparaíso
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Chile, Curico Maule
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Chile, Talca Maule
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
Israel, Be'er Sheva South District
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
Israel, Haifa Haifa District
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
Israel, Jerusalem Jerusalem District
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
Israel, Nahariyya North District
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
Israel, Nazareth North District
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
Israel, Petah Tikva Center District
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United Kingdom, Glasgow Scotland
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United Kingdom, London England
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United Kingdom, England
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United Kingdom, Norwich England
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United Kingdom, Nottingham England
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United Kingdom, England
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
Germany, Mannheim Baden-Württemberg
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
Germany, Jena Thuringia
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
Germany, Hanover Lower Saxony
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
Germany, Munich Bavaria
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
Germany, Bonn North Rhine-Westphalia
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
Germany, Frankfurt Hessen
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United Kingdom, Oxford England
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, San Antonio Texas
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, Richmond Virginia
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, Chicago Illinois
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, Dallas Texas
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, New York New York
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, Sacramento California
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, New York New York
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, Boston Massachusetts
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, Germantown Tennessee
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, San Diego California
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, Charleston South Carolina
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, Cleveland Ohio
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, New York
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
Germany, Hamburg Hamburg
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, Colorado Springs Colorado
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
Spain, Valencia Valencian Community
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
Israel, Be'er Ya'akov Center District
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
Ireland, County Dublin
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
Spain, Zaragoza Aragon
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, Cincinnati Ohio
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, Richmond Virginia
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, Charlotte North Carolina
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
United States, Lancaster California
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Murrieta California
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Sun City Arizona
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Little Rock Arkansas
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Lancaster California
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Harrisburg Pennsylvania
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Lynchburg Virginia
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Los Angeles California
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Clearwater Florida
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Clearwater Florida
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Atlanta Georgia
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Wyoming Michigan
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Gurnee Illinois
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Oklahoma City Oklahoma
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, San Marcos Texas
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Topeka Kansas
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Dothan Alabama
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Chapel Hill North Carolina
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Los Angeles California
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Dublin Ohio
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Boston Massachusetts
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Garden Grove California
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Chesapeake Virginia
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Idaho Falls Idaho
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Jacksonville Florida
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Nashville Tennessee
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Kingsport Tennessee
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Jackson Township New Jersey
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Lafayette Louisiana
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Austin Texas
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Oklahoma City Oklahoma
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, San Francisco California
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Orange California
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Garland Texas
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Lakeland Florida
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Miami Florida
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Fayetteville North Carolina
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Decatur Georgia
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, New Albany Indiana
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Cincinnati Ohio
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Mentor Ohio
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Lakeland Florida
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Chicago Illinois
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Rapid City South Dakota
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Minneapolis Minnesota
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Birmingham Alabama
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Glenview Illinois
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Boynton Beach Florida
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Chicago Illinois
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Chicago Illinois
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Durham North Carolina
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Salt Lake City Utah
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Los Angeles California
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
Belgium, Roeselare Vlaams Gewest
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
Belgium, Brugge Vlaams Gewest
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
Belgium, Leuven Vlaams Gewest
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
Belgium, Tournai Région Wallonne
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
Australia, Maroochydore Queensland
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
Australia, North Mackay Queensland
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
Australia, Ballarat Central Victoria
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
Netherlands, Amsterdam Noord-Holland
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Knoxville Tennessee
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Inverness Florida
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
Australia, Epping Victoria
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Wyomissing Pennsylvania
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Huntsville Alabama
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
Australia, Footscray Victoria
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Webster Texas
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
Germany, Hannover Niedersachsen
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
Australia, Woolloongabba Queensland
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
United States, Kissimmee Florida
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Naples Florida
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Lawrenceville Georgia
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Charlotte North Carolina
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Charlotte North Carolina
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Huntersville North Carolina
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Winston-Salem North Carolina
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Altoona Pennsylvania
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Charleston South Carolina
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Rock Hill South Carolina
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Franklin Tennessee
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Dallas Texas
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Birmingham Alabama
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Lawrenceville Georgia
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Rincon Georgia
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Charlotte North Carolina
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Charlotte North Carolina
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Huntersville North Carolina
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Altoona Pennsylvania
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Charleston South Carolina
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Franklin Tennessee
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Hendersonville Tennessee
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Dallas Texas
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, San Antonio Texas
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
Australia, Chermside West Queensland
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
New Zealand, Havelock North Hawke's Bay
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
New Zealand, Christchurch Canterbury
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, New Orleans Louisiana
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Clearwater Florida
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, New York New York
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Philadelphia Pennsylvania
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Baltimore Maryland
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Tyler Texas
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, St. Petersburg Florida
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Sarasota Florida
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Tampa Florida
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, New York
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, St. Louis Missouri
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Springfield Illinois
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Santa Barbara California
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, San Diego California
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Cincinnati Ohio
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- Eosinophilic Esophagitis Clinical Trial
- Recruiting - PWT010302020
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Hillsborough Township New Jersey
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Weston Florida
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Omaha Nebraska
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Columbus Ohio
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, New York
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- Primary Sclerosing Cholangitis Clinical Trial
- Recruiting - NCT04595825
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
Australia, Adelaide South Australia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
Australia, Greenslopes Queensland
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Augusta Georgia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Portland Oregon
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Chicago Illinois
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
Australia, Perth Western Australia
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Springfield Illinois
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
Canada, Windsor Ontario
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Atlanta Georgia
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Fresno California
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
New Zealand, Auckland Auckland
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
Spain, Comunidad de Madrid
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Denver Colorado
- Non-Cystic Fibrosis Bronchiectasis Clinical Trial
- Recruiting - NCT04594369
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
United States, Syracuse New York
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Phoenix Arizona
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Philadelphia Pennsylvania
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Orange California
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Hackensack New Jersey
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Woodmere New York
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Amherst New York
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Springfield Illinois
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Indianapolis Indiana
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Pensacola Florida
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Seattle Washington
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, East Lansing Michigan
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Lexington Kentucky
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Salt Lake City Utah
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Kansas City Kansas
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Bethesda Maryland
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Orlando Florida
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Los Angeles California
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Mobile Alabama
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Boston Massachusetts
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Boise Idaho
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Aurora Colorado
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Ann Arbor Michigan
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Charleston South Carolina
- MAC Lung Disease Clinical Trial
- Recruiting - NCT04677569
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United States, Suwanee Georgia
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
United Kingdom, England
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
- PW TEST PGTCS
- Recruiting - PWTID0817202302
United States, Iowa City Iowa
- Warm Autoimmune Hemolytic Anemia Clinical Trial
- Recruiting - NCT05786573
United States, Greenville North Carolina
- Warm Autoimmune Hemolytic Anemia Clinical Trial
- Recruiting - NCT05786573
United States, Washington District of Columbia
- Warm Autoimmune Hemolytic Anemia Clinical Trial
- Recruiting - NCT05786573
United States, Oklahoma City Oklahoma
- Warm Autoimmune Hemolytic Anemia Clinical Trial
- Recruiting - NCT05786573
United States, San Diego California
- Warm Autoimmune Hemolytic Anemia Clinical Trial
- Recruiting - NCT05786573
United States, Los Angeles California
- Warm Autoimmune Hemolytic Anemia Clinical Trial
- Recruiting - NCT05786573
United Kingdom, England
- PW TEST PGTCS
- Recruiting - PWTID0817202302
United Kingdom, England
- Primary Generalized Tonic-Clonic Seizures Clinical Trial
- Recruiting - NCT05667142
- PW TEST PGTCS
- Recruiting - PWTID0817202302
United States, Madison Wisconsin
- Posttraumatic Stress Disorder Clinical Trial
- Recruiting - NCT01947725
Featured Trial
Myelodysplastic Syndromes Clinical Trial
The goal of this study is to evaluate whether the investigational drug will help patients with lower-risk MDS improve their symptoms and reduce their number of transfusions.
Recruiting
Male & Female
18 Years +
Featured Trial
Mild Traumatic Brain Injury & PTSD Study
This study is evaluating potential treatments to reduce attention problems and improve everyday function for patients with PTSD and mild traumatic brain injury. Over the course of 10 weeks, this study will use a combination of two treatments: 1. Interactive computer attention processing trai...
Recruiting
Male & Female
18 - 60
Years old
Featured Trial
Non-Cystic Fibrosis Bronchiectasis Clinical Trial
In the ASPEN study, you will be seen by NCFBE experts and receive study related treatment at no cost, a comprehensive study-related health check during your participation (62 weeks), and travel reimbursement.
Recruiting
Male & Female
18 - 85
Years old
Featured Trial
Primary Sclerosing Cholangitis Clinical Trial
This study is designed to assess the safety, tolerability and activity of CM-101 in patients with Primary Sclerosing Cholangitis (PSC).
Recruiting
Male & Female
18 - 75
Years old
Featured Trial
Eosinophilic Esophagitis Clinical Trial
In the VOYAGE study you will be seen by EoE specialists, help advance EoE research and you may receive an investigational drug that may have the potential to provide relief to your symptoms.
Recruiting
Male & Female
18 - 65
Milliseconds old
Featured Trial
MAC Lung Disease Clinical Trial
In the study, you will be seen by MAC experts and may receive a study treatment being evaluated for potential treatment of MAC lung infections.
Recruiting
Male & Female
18 Years +
Featured Trial
Primary Generalized Tonic-Clonic Seizures Clini...
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of XEN1101 administered as adjunctive treatment in primary generalized tonic-clonic seizures (PGTCS).
Recruiting
Male & Female
18 Years +
Featured Trial
Warm Autoimmune Hemolytic Anemia Clinical Trial
This study aims to examine the efficacy and safety of obexelimab in participants with Warm Autoimmune Hemolytic Anemia (wAIHA).
Recruiting
Male & Female
18 Years +
Featured Trial
PW TEST PGTCS
PGTCS Test
Recruiting
Female
All ages
Posttraumatic Stress Disorder Clinical Trial
The purpose of this study is to examine whether behavioral activation as an adjuvant to standard smoking cessation treatment improves smoking cessation outcomes among veterans with PTSD relative to a comparably intense combination of standard smoking cessation treatment + health...
Recruiting
Male & Female
18 Years +
Connect with PatientWing
Like Us Follow UsGet all the latest studies in your inbox! Sign up for the PatientWing newsletter today!
Sign me upLooking to enroll patients? List your studies here
Streamline your enrollment process and get better qualified patients through PatientWing.
Get startedHealthy and want to help?
By participating in clinical trials, you help advance the medical science and may be compensated for your time. Hooray!!
See what's available